Biohaven BHVN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$130.53M+41.1% | -$145.56M+22.1% | -$173.44M-8.2% | -$198.15M+38.0% | -$221.68M-23.5% | ||
| $2.37M+5.3% | $2.57M+4.6% | $3.13M+56.7% | $1.98M+1.2% | $2.25M+55.3% | ||
| $28.29M-46.7% | $16.95M+33.5% | $21.54M+77.1% | $20.81M+70.1% | $53.06M+52.1% | ||
| -$1.22M-1,442% | -$5.85M— | -$2.14M-186% | $1.51M+108% | $91K-99.5% | ||
| -$64.41M-2,415% | —— | —— | $21.59M+223% | $2.78M-69.7% | ||
| -$12.56M-274% | -$8.82M-5.8% | -$6.5M+50.8% | $4.54M-58.2% | $7.24M+176% | ||
| $837K-70.6% | -$5.58M-213% | $1.16M-67.9% | $1.4M-32.3% | $2.84M+169% | ||
| -$149.92M+9.2% | -$130.66M+23.5% | -$145.72M-3.1% | -$167.94M-0.1% | -$165.12M-60.9% | ||
| $0-100% | $8K-83.7% | $13K-97.9% | $233K-92.1% | $461K+4.8% | ||
| $19.79M-55.7% | $88.73M-68.3% | $0-100% | $133.48M-32.0% | $44.66M-5.1% | ||
| $35M-83.3% | -$495M-58.5% | $165M— | $120M— | $210M+159% | ||
| $15.21M-90.8% | —— | $164.97M+277% | —— | $164.88M+384% | ||
| $178.88M— | $189.18M-30.3% | $0-100% | $0-100% | $0-100% | ||
| $0— | -$194K— | $0— | $0-100% | $0-100% | ||
| $179.02M+48,414% | $188.8M-30.8% | $122K-99.8% | $249.83M-22.2% | $369K-89.2% | ||
| $16K-30.4% | —— | —— | -$40K-471% | $23K+483% | ||
| $44.33M+30,054% | $44.4M— | $19.39M+113% | $66.31M— | $147K+100% | ||
| —— | $54K+72.8% | $54K+72.8% | $54K+72.8% | $54K+72.8% | ||
| $0+100% | —— | —— | —— | -$3.61M-181% | ||
| $3.01M— | —— | -$11.2M— | -$1.19M— | $0— | ||
| -$64.41M-2,415% | —— | —— | $21.59M+223% | $2.78M-69.7% | ||
| -$12.56M-274% | -$8.82M-5.8% | -$6.5M+50.8% | $4.54M-58.2% | $7.24M+176% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $837K-70.6% | -$5.58M-213% | $1.16M-67.9% | $1.4M-32.3% | $2.84M+169% | ||
| $858K-82.3% | —— | —— | —— | $4.84M-14.1% | ||
| $35M-83.3% | $75M-60.9% | $165M+26.9% | $120M+18.6% | $210M+159% | ||
| $132K-64.2% | —— | —— | —— | $369K-87.2% | ||
| $0— | -$194K— | $0— | $0-100% | $0-100% | ||
| -$149.92M+9.5% | -$130.67M+23.5% | -$145.73M-2.7% | -$168.17M+1.5% | -$165.59M-60.6% | ||
| -$149.92M+9.5% | -$130.67M+23.5% | -$145.73M-2.7% | -$168.17M+1.5% | -$165.59M-60.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Biohaven's cash flow data come from?
- Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.